Sperans James 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 24, 2012
Insider Transaction Report
Form 4
Sperans James
Director
Transactions
- Award
Restricted Stock Units
2012-02-22+2,268→ 2,268 total→ Common Stock (2,268 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of SGNT common stock.
- [F2]The restricted stock units vest in four equal annual installments beginning on February 22, 2013. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.